Report Detail
Global Gene Therapy on Neurological Diseases Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
- RnM4342555 |
- 13 September, 2021 |
- Global |
- Pages: NA |
- QYResearch |
- Pharma & Healthcare
Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
Market Insights
QY Research has lately published a report titled “Global Gene Therapy on Neurological Diseases Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application”, with the help of industry-leading research methods, along with observing subtle details and understanding the overall dynamics.
The insights included in this report have been prepared in view of varied aspects that affect the growth. The report elucidates key drivers, trends, prospects, restraining factors, and challenges that players may across in the coming years. With the assistance of this research, players can recognize and capitalize on profitable opportunities. They can further utilize it to make the required advancements in their operations to acquire a competitive advantage over other participants.
The global Gene Therapy on Neurological Diseases market size is projected to reach US$ million by 2027, from US$ million in 2020, at a CAGR of % during 2021-2027.
Segment Scope
An intensive study of key type and application segments has been done in this segmentation section. The authors of the report have provided reliable figures including revenue forecast data by type and application for the period 2016-2027. They have also studied how the segments are gaining or losing growth in various geographies and their respective countries. Thanks to this study, readers can thoroughly grasp the growth pattern and potential of different segments.
Segment by Type
Viral Gene Therapy
Non-viral Gene Therapy
Segment by Application
Hospital
Clinic
Other
Regional Scope
This segment of the report offers a thorough regional study of the global Gene Therapy on Neurological Diseases market. Drivers and restraints for each region are broadly examined in the report. Readers will get familiar with the driving forces and challenges that are specific to the regions. The specialists have identified growth opportunities in key geographical regions and their respective countries to aid players to reinforce their presence. All the regions and their countries in the report are assessed based on the growth rate and revenue according to the consumption for the period 2016-2027. This geographical analysis will help readers to gain in-depth knowledge of the regional growth. The key geographical regions surveyed in this research report involve North America, Europe, Asia Pacific, Central and South America, and Middle East and Africa. The report has specifically covered major countries including United States, Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
Key Players
This section has provided an exhaustive analysis of the strategies that the companies are focusing on to stay ahead of other players. The strategies mainly involve research and development, new product developments, and mergers and acquisitions. The researchers have also provided revenue shares of the key companies, company overview, and the latest company developments so as to help players to sustain the cutthroat competition. In this section, the report offers global revenue data of manufacturers for the period 2016-2021. Following is the list of key manufacturers observed in this research study:
Biogen
Novartis
Sarepta Therapeutics
Table of Contents
1 Market Overview of Gene Therapy on Neurological Diseases
- 1.1 Gene Therapy on Neurological Diseases Market Overview
- 1.1.1 Gene Therapy on Neurological Diseases Product Scope
- 1.1.2 Gene Therapy on Neurological Diseases Market Status and Outlook
- 1.2 Global Gene Therapy on Neurological Diseases Market Size Overview by Region 2016 VS 2021 VS 2027
- 1.3 Global Gene Therapy on Neurological Diseases Market Size by Region (2016-2027)
- 1.4 Global Gene Therapy on Neurological Diseases Historic Market Size by Region (2016-2021)
- 1.5 Global Gene Therapy on Neurological Diseases Market Size Forecast by Region (2022-2027)
- 1.6 Key Regions, Gene Therapy on Neurological Diseases Market Size (2016-2027)
- 1.6.1 North America Gene Therapy on Neurological Diseases Market Size (2016-2027)
- 1.6.2 Europe Gene Therapy on Neurological Diseases Market Size (2016-2027)
- 1.6.3 Asia-Pacific Gene Therapy on Neurological Diseases Market Size (2016-2027)
- 1.6.4 Latin America Gene Therapy on Neurological Diseases Market Size (2016-2027)
- 1.6.5 Middle East & Africa Gene Therapy on Neurological Diseases Market Size (2016-2027)
2 Gene Therapy on Neurological Diseases Market Overview by Type
- 2.1 Global Gene Therapy on Neurological Diseases Market Size by Type: 2016 VS 2021 VS 2027
- 2.2 Global Gene Therapy on Neurological Diseases Historic Market Size by Type (2016-2021)
- 2.3 Global Gene Therapy on Neurological Diseases Forecasted Market Size by Type (2022-2027)
- 2.4 Viral Gene Therapy
- 2.5 Non-viral Gene Therapy
3 Gene Therapy on Neurological Diseases Market Overview by Application
- 3.1 Global Gene Therapy on Neurological Diseases Market Size by Application: 2016 VS 2021 VS 2027
- 3.2 Global Gene Therapy on Neurological Diseases Historic Market Size by Application (2016-2021)
- 3.3 Global Gene Therapy on Neurological Diseases Forecasted Market Size by Application (2022-2027)
- 3.4 Hospital
- 3.5 Clinic
- 3.6 Other
4 Gene Therapy on Neurological Diseases Competition Analysis by Players
- 4.1 Global Gene Therapy on Neurological Diseases Market Size by Players (2016-2021)
- 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gene Therapy on Neurological Diseases as of 2020)
- 4.3 Date of Key Players Enter into Gene Therapy on Neurological Diseases Market
- 4.4 Global Top Players Gene Therapy on Neurological Diseases Headquarters and Area Served
- 4.5 Key Players Gene Therapy on Neurological Diseases Product Solution and Service
- 4.6 Competitive Status
- 4.6.1 Gene Therapy on Neurological Diseases Market Concentration Rate
- 4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
- 5.1 Biogen
- 5.1.1 Biogen Profile
- 5.1.2 Biogen Main Business
- 5.1.3 Biogen Gene Therapy on Neurological Diseases Products, Services and Solutions
- 5.1.4 Biogen Gene Therapy on Neurological Diseases Revenue (US$ Million) & (2016-2021)
- 5.1.5 Biogen Recent Developments
- 5.2 Novartis
- 5.2.1 Novartis Profile
- 5.2.2 Novartis Main Business
- 5.2.3 Novartis Gene Therapy on Neurological Diseases Products, Services and Solutions
- 5.2.4 Novartis Gene Therapy on Neurological Diseases Revenue (US$ Million) & (2016-2021)
- 5.2.5 Novartis Recent Developments
- 5.3 Sarepta Therapeutics
- 5.3.1 Sarepta Therapeutics Profile
- 5.3.2 Sarepta Therapeutics Main Business
- 5.3.3 Sarepta Therapeutics Gene Therapy on Neurological Diseases Products, Services and Solutions
- 5.3.4 Sarepta Therapeutics Gene Therapy on Neurological Diseases Revenue (US$ Million) & (2016-2021)
- 5.3.5 Recent Developments
6 North America
- 6.1 North America Gene Therapy on Neurological Diseases Market Size by Country (2016-2027)
- 6.2 United States
- 6.3 Canada
7 Europe
- 7.1 Europe Gene Therapy on Neurological Diseases Market Size by Country (2016-2027)
- 7.2 Germany
- 7.3 France
- 7.4 U.K.
- 7.5 Italy
- 7.6 Russia
- 7.7 Nordic
- 7.8 Rest of Europe
8 Asia-Pacific
- 8.1 Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Region (2016-2027)
- 8.2 China
- 8.3 Japan
- 8.4 South Korea
- 8.5 Southeast Asia
- 8.6 India
- 8.7 Australia
- 8.8 Rest of Asia-Pacific
9 Latin America
- 9.1 Latin America Gene Therapy on Neurological Diseases Market Size by Country (2016-2027)
- 9.2 Mexico
- 9.3 Brazil
- 9.4 Rest of Latin America
10 Middle East & Africa
- 10.1 Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Country (2016-2027)
- 10.2 Turkey
- 10.3 Saudi Arabia
- 10.4 UAE
- 10.5 Rest of Middle East & Africa
11 Gene Therapy on Neurological Diseases Market Dynamics
- 11.1 Gene Therapy on Neurological Diseases Industry Trends
- 11.2 Gene Therapy on Neurological Diseases Market Drivers
- 11.3 Gene Therapy on Neurological Diseases Market Challenges
- 11.4 Gene Therapy on Neurological Diseases Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Disclaimer
Summary:
Get latest Market Research Reports on Gene Therapy on Neurological Diseases. Industry analysis & Market Report on Gene Therapy on Neurological Diseases is a syndicated market report, published as Global Gene Therapy on Neurological Diseases Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application. It is complete Research Study and Industry Analysis of Gene Therapy on Neurological Diseases market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
